The Journal of Nutritional Biochemistry
Volume 21, Issue 8 , Pages 749-756 , August 2010

Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction

  • Manabu Isoda

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Haruo Hanawa

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • Corresponding Author InformationCorresponding author.
    • ,
  • Ritsuo Watanabe

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Tsuyoshi Yoshida

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Ken Toba

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Kaori Yoshida

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Mayuko Kojima

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Keita Otaki

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Kazuhisa Hao

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Limin Ding

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Komei Tanaka

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Tsugumi Takayama

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Kiminori Kato

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Yuji Okura

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Makoto Kodama

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Yoshimi Ota

      Affiliations

    • Faculty of Medicine, Department of Medical Technology, School of Health Sciences, Niigata University, Niigata 951-8518, Japan
    • ,
  • Junichi Hayashi

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan
    • ,
  • Yoshifusa Aizawa

      Affiliations

    • Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8120, Japan

Received 15 January 2009 ,Revised 9 April 2009 ,Accepted 28 April 2009.

References 

  1. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147–150
  2. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806–7810
  3. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–2463
  4. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093
  5. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819
  6. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–1044
  7. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276
  8. Oates PS, Ahmed U. Molecular regulation of hepatic expression of iron regulatory hormone hepcidin. J Gastroenterol Hepatol. 2007;22:1378–1387
  9. Aisen P, Enns C, Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol. 2001;33:940–959
  10. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783–788
  11. Halliwell B, Gutteridge JM. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett. 1992;307:108–112
  12. Walters FP, Kennedy FG, Jones DP. Oxidation of myoglobin in isolated adult rat cardiac myocytes by 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid. FEBS Lett. 1983;163:292–296
  13. Baron CP, Andersen HJ. Myoglobin-induced lipid oxidation. A review. J Agric Food Chem. 2002;50:3887–3897
  14. Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, et al. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation. 2004;109:1877–1885
  15. Turoczi T, Jun L, Cordis G, Morris JE, Maulik N, Stevens RG, et al. HFE mutation and dietary iron content interact to increase ischemia/reperfusion injury of the heart in mice. Circ Res. 2003;92:1240–1246
  16. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology. 2007;148:2663–2668
  17. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1990;57:250–262
  18. Kodama M, Zhang S, Hanawa H, Shibata A. Immunohistochemical characterization of infiltrating mononuclear cells in the rat heart with experimental autoimmune giant cell myocarditis. Clin Exp Immunol. 1992;90:330–335
  19. Hanawa H, Abe S, Hayashi M, Yoshida T, Yoshida K, Shiono T, et al. Time course of gene expression in rat experimental autoimmune myocarditis. Clin Sci (Lond). 2002;103:623–632
  20. Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, Watanabe R, et al. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol. 2006;177:3635–3643
  21. Frangogiannis NG. The mechanistic basis of infarct healing. Antioxid Redox Signal. 2006;8:1907–1939
  22. Parsons WJ, Williams RS, Shelton JM, Luo Y, Kessler DJ, Richardson JA. Developmental regulation of cytochrome oxidase subunit VIa isoforms in cardiac and skeletal muscle. Am J Physiol. 1996;270:H567–H574
  23. Yoshida T, Hanawa H, Toba K, Watanabe H, Watanabe R, Yoshida K, et al. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc Res. 2005;68:278–288
  24. Schlerf A, Droste M, Winter M, Kadenbach B. Characterization of two different genes (cDNA) for cytochrome c oxidase subunit VIa from heart and liver of the rat. EMBO J. 1988;7:2387–2391
  25. Nakamura S, Naruse M, Naruse K, Kawana M, Nishikawa T, Hosoda S, et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am J Hypertens. 1991;4:909–912
  26. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109:353–358
  27. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007;117:1926–1932
  28. Pardoll DM. Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol. 1995;13:399–415
  29. Yamauchi-Takihara K, Kishimoto T. Cytokines and their receptors in cardiovascular diseases — role of gp130 signalling pathway in cardiac myocyte growth and maintenance. Int J Exp Pathol. 2000;81:1–16
  30. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood. 2006;107:328–333
  31. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776–781
  32. Mladenka P, Simunek T, Hubl M, Hrdina R. The role of reactive oxygen and nitrogen species in cellular iron metabolism. Free Radic Res. 2006;40:263–272
  33. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992;267:18148–18153
  34. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737–1744
  35. van der Putten K, Braam B, Jie KE, Gaillard CA. Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol. 2008;4:47–57
  36. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055–2059
  37. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241
  38. Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2002;17:39–43

☆ This study was supported in part by a Ministry of Health, Labor, and Welfare in Japan Grant “Research on Regulatory Science of Pharmaceutical and Medical Devices.” and by a Grant for scientific research from the Ministry of Education, Science and Culture of Japan (number 20591185).

PII: S0955-2863(09)00103-X

doi: 10.1016/j.jnutbio.2009.04.009

The Journal of Nutritional Biochemistry
Volume 21, Issue 8 , Pages 749-756 , August 2010

Article Tools

* Image Usage & Resolution